A. Tsianakas, “Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU)”, Acta Derm Venereol, vol. 99, no. 4, pp. 379–385, Feb. 2019.